Search

everythinglearnresearchcommunity

for

Search:↓

New treatments for hair growth and psoriasis may be possible, and gene differences could affect baldness and the severity of skin conditions.

R-spondin2 may help treat hair loss, gene differences could explain baldness, a peptide's regulation is linked to psoriasis, B-defensin gene copies may affect a skin condition's risk and severity, and potential markers and targets for alopecia areata were identified.

Female hair loss is often hereditary and can be treated with medication, hair transplants, and lasers.

Boosting HGF signaling could improve the creation of hair follicles in lab-made skin.

RPGRIP1L helps skin cells stick together by blocking PKCβII, which can prevent skin blistering like in pemphigus.

Applying the anti-cancer drug Bortezomib to skin can promote hair growth and increase hair proteins through the GATA-3 factor.

IL6 is linked to higher risk of heart disease in people with a certain mouth condition.

Different connective tissue disorders have unique symptoms and treatments, with varying outcomes and often require ongoing care from a specialist.

Adalimumab can cause complete hair loss in rare cases.

Inflammasome proteins can indicate the severity and treatment response of various diseases and injuries.

Some plant-based ingredients may help with hair growth and care, but more research is needed to confirm their effectiveness.

Hair follicles help attract immune cells to minor skin injuries.

Lichen planopilaris is a rare, chronic condition causing hair loss, mainly in middle-aged women, and early treatment is important to prevent permanent baldness.

About 30% of women feel they lose too much hair, often starting before age 40, and most can't find a reason for it.

A woman with Degos disease managed her condition for nine years with medications and had two healthy pregnancies, while a separate finding suggests a possible link between female pattern hair loss and high blood pressure.

A woman with thymoma developed a rare chronic condition similar to graft versus host disease after surgery.

The document concludes that using gadolinium-based contrast agents during MRI can be linked to Nephrogenic Systemic Fibrosis in patients with severe kidney disease.

Several genes, including Hox-7A, Stra6, and Lim-1, are involved in normal palate formation.

Blocking IL-1 could help treat some hair loss conditions; alopecia affects liver detox systems; spironolactone is better than finasteride for female hair growth; focusing on the catagen hair phase could lead to new alopecia treatments.

Alopecia patients have a less active liver monoxygenase system, which can be treated with photochemotherapy and system inducers.

Spironolactone is more effective than finasteride in treating excessive hair growth in women.

T cells and bacteria in the gut and skin help maintain health and protect against disease.

Patients need better information about the risks of long-term steroid use.

Leflunomide is effective for rheumatoid arthritis but has significant side effects.

Different cells affect hair follicle blood vessels, endothelial cells react differently to inflammation and oxidized fats, and prasugrel better protects heart vessels during a procedure than clopidogrel.

Prasugrel is better than clopidogrel at preventing heart damage and improving blood flow in small heart vessels during heart artery procedures.

There's a growing resistance to the antibiotic mupirocin in children's skin infections caused by MRSA in New York.

Treatment with biologic agents can significantly improve psoriasis symptoms, and blood biomarkers could potentially predict individual patient's response to treatment.

Women with androgenetic alopecia may have higher blood pressure levels.

Testosterone metabolism in balding scalp cells may not be the main cause of hair loss.